Background Helicobacter pylori (H. pylori) affects nearly half of the world's populations with
high incidence and prevalence rates in developing countries. Infection with H. pylori …

Helicobacter pylori (H pylori) infection is one of the most common chronic bacterial infections
worldwide. International guidelines recommend H pylori eradication in several scenarios …

The management of Helicobacter pylori (H. pylori) infection treatment differs from the
common treatment protocol for other infectious diseases. Because culture-or molecular …

As the rate of discovery of drug-resistant Helicobacter pylori cases increases worldwide, the
relevant societies have updated their guidelines for primary eradication regimens. A …

Helicobacter pylori is a common bacterial pathogen responsible for substantial
gastrointestinal morbidity worldwide. Helicobacter pylori infection can be clinically …

Annually hundreds if not thousands of patients fail empiric H pylori eradication therapy.
Failure occurs in part because routine post treatment testing, which provides an early …

Helicobacter pylori (H. pylori) remains a prevalent, worldwide, chronic infection. Though the
prevalence of this infection appears to be decreasing in many parts of the world, H. pylori …

Background: An antimicrobial susceptibility test for Helicobacter pylori before second‐line
treatment is often performed, although whether the test is truly necessary remains unknown …

Helicobacter pylori infection remains one of the most prevalent infections worldwide,
especially in low-resource countries, and the major risk factor for peptic ulcer and gastric …

Helicobacter pylori infection is an infectious disease. Given the alarmingly high antibiotic
resistance in H. pylori, gastroenterologists should change the empiric H. pylori treatment …